ES Corporate Technology announces OrthoMediTec conducted 3 WaisFix100™ successful clinical trials

OrthoMediTec is a privately held medical device company, specializing in the field of orthopedic trauma solutions. The company provides surgeons with devices for the treatment of patients in orthopedic trauma care. WaisFix100™ is a groundbreaking solution for the treatment of proximal femoral fracture, a major market within trauma care. Current fixation failure rates for femoral fractures are high using current surgical methods; fractures have average failure rates of up to 45%. WaisFix100™ is the first commercially available device that reduces morbidity and mortality by increasing recovery rates and reducing blood loss and damage to tissue. The WaisFix100™ fixation device is designed to provide benefits such as minimally invasive accelerated fixation and early weight-bearing. The approval from the Ministry of Health (AMA”R) was granted in June, 2007. First three cases successfully performed at the Carmel medical centre, Haifa, Israel.

Shahar Namer
Managing Partner

Equity Source Corporate Technology Ltd.
32 College Close
Flamstead
Hertfordshire
AL3 8DJ
United Kingdom

Tel: +44-(0)20 8819 7828
Fax: +44-(0)15 8284 3896
Mobile: +44-(0)-793 240 5703

E-mail: s.namer@equitysource.co.uk
Web site: www.equitysource.co.uk

With its head office in the United Kingdom, Equity Source is the only independent corporate technology firm focused on identifying valuable developments and facilitating new strategic partnerships.

This release was published on openPR.